Federal Register of Legislation - Australian Government

Primary content

Standards/Other as made
This instrument amends the Poisons Standard February 2020 in relation to the substance hydroxychloroquine, principally to ensure the continued availability of medicines containing this substance in Australia during the public health emergency caused by the outbreak of the disease known as coronavirus disease (COVID-19).
Administered by: Health
Registered 02 Apr 2020
Tabling HistoryDate
Tabled HR08-Apr-2020
Tabled Senate08-Apr-2020
Date of repeal 04 Apr 2020
Repealed by Division 1 of Part 3 of Chapter 3 of the Legislation Act 2003
Table of contents.

Commonwealth Coat of Arms of Australia

 

Poisons Standard Amendment (Hydroxychloroquine) Instrument 2020

I, Tony Gill, as delegate of the Secretary of the Department of Health, make the following instrument.

Dated 2 April 2020

Tony Gill

Principal Medical Adviser

Prescription Medicines Authorisation Branch

Health Products Regulation Group

Department of Health

 


Contents

1  Name........................................................................................................................................ 1

2  Commencement........................................................................................................................ 1

3  Authority.................................................................................................................................. 1

4  Schedules................................................................................................................................. 1

Schedule 1—Amendments                                                                                           2

Poisons Standard February 2020                                                                                                      2

 

 


1  Name

                   This instrument is the Poisons Standard Amendment (Hydroxychloroquine) Instrument 2020.

2  Commencement

             (1)  Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

 

Commencement information

Column 1

Column 2

Column 3

Provisions

Commencement

Date/Details

1. The whole of this instrument

The day after this instrument is registered.

3 April 2020

Note:          This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.

             (2)  Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.

3  Authority

                   This instrument is made under paragraph 52D(2)(a) of the Therapeutic Goods Act 1989.

4  Schedules

                   Each instrument that is specified in Schedule 1 is amended or repealed as set out in the applicable items in that Schedule, and any other item has effect according to its terms.

Schedule 1Amendments

Poisons Standard February 2020

1  Appendix D of Part 5 of Schedule 2 (item 8)

            Repeal the item, substitute:

 

8.

Poisons for which the initial treatment of a patient must be authorised by one of the following specialist health practitioners:

 

(1)

following the commencement of the Poisons Standard Amendment (Hydroxychloroquine and Salbutamol) Instrument 2020—a medical practitioner registered under State or Territory legislation that forms part of the Health Practitioner Regulation National Law, as a specialist in any of the following recognised specialties:

(a) dermatology;

(b) emergency medicine;

(c) intensive care medicine;

(d) paediatrics and child health;

(e) physician;

 

(2)

following the commencement of the Poisons Standard Amendment (Hydroxychloroquine) Instrument 2020—a dental practitioner registered under State or Territory legislation that forms part of the Health Practitioner Regulation National Law, as a specialist in the recognised specialty of oral medicine.

 

HYDROXYCHLOROQUINE.